Compound class:
Synthetic organic
Comment: JEDI-852 is the hit molecule from a series of antibacterial compounds that target UDP-2,3-diacylglucosamine hydrolase (LpxH), an enzyme in the lipopolysaccharide synthesis pathway [1]. LpxH is an essential enzyme, conserved in the majority of Gram-negative bacteria but absent in human.
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
2-(methyl-methylsulfonylamino)-N-(4-piperidin-1-ylsulfonylphenyl)benzamide |
Database Links ![]() |
|
Specialist databases | |
Antibiotic DB
![]() |
JEDI-852 |
Other databases | |
ChEMBL Ligand | CHEMBL1432883 |
GtoPdb PubChem SID | 496703302 |
PubChem CID | 1228113 |
RCSB PDB Ligand | VTK |
Search Google for chemical match using the InChIKey | WMMQKHOYQUOGHM-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | WMMQKHOYQUOGHM |
UniChem Compound Search for chemical match using the InChIKey | WMMQKHOYQUOGHM-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | WMMQKHOYQUOGHM-UHFFFAOYSA-N |